FDA Inspection
Lonza Bend Inc.Lonza Bend Inc. – FDA Inspection, May 24, 2023
Record Details
This FDA Inspection record concerns Lonza Bend Inc., with an inspection on May 24, 2023, issued by the Seattle District Office.
- Company
- Lonza Bend Inc.
- Inspection Date
- May 24, 2023
View Company Profile
ID · b41518ab-978c-4426-bb17-e056e3159d55
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1206164
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.84(d)(1)Component identity verification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lonza Bend Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 19, 2026 | Not classified | Seattle District Office | Drug Quality Assurance |
| August 5, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 27, 2018 | Not classified | Seattle District Office | |
| July 27, 2018 | Not classified | Seattle District Office | |
| July 21, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lonza Bend Inc.
- FDA Inspection 1317820 - 2026-05-19
- FDA Inspection 1178398 - 2022-08-05
- FDA Inspection 1065493 - 2018-07-27
- FDA Inspection 1060190 - 2018-07-27
- FDA Inspection 1018924 - 2017-07-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.